Company: FVN
Filing Date: 2025-03-27
Form Type: DRS/A
Source: 0001829126-25-002094
Chunk: 139

Company: Future Vision II Acquisition Corp.
Filing Date: 2025-03-27
Form: DRS/A
Chunk 139
---
inging on other marks, as applicable. We may not be able to protect our rights to these trademarks and trade names, which we will need to build name recognition by potential collaborators or customers in our markets of interest. Over the long term, if we are unable to establish name recognition based on our trademarks and trade names, we may not be able to compete effectively and our business may be adversely affected.

If our efforts to protect the proprietary nature of the intellectual property related to our technologies are not adequate, we may not be able to compete effectively in our market.

We rely upon a combination of patents, confidentiality agreements, trade secret protection and intellectual property and confidentiality agreements to protect the intellectual property related to our technologies and our products. Any disclosure to or misappropriation by third parties of our confidential proprietary information could enable competitors to quickly duplicate or surpass our technological achievements, thus eroding our competitive position in our market.

<div align='center'>75</div>

We have approved PRC patent applications in our portfolio and may have future pending patent, trademark and other intellectual property rights applications; however, we cannot predict:

| ● | If and when patents will issue based on our applications;                                                                                                                                  |
| ● | The scope of protection of any patent issuing based on our applications;                                                                                                                   |
| ● | The degree and range of protection any issued patents will afford us against competitors including whether third parties will find ways to invalidate or otherwise circumvent our patents; |
| ● | Whether any of our intellectual property will provide any competitive advantage;                                                                                                           |
| ● | Whether or not others will obtain patents claiming aspects similar to those covered by our patents and patent applications;                                                                |
| ● | Whether we will need to initiate or defend litigation or administrative proceedings to enforce and/or defend our patent rights, which may be costly whether we win or lose; or             |
| ● | Whether the patent applications that we own or may in-license will result in issued patents with claims that cover our product candidates or uses thereof in any countries.                |

<div align='center'>76</div>

Risks Related to New VIWO’s Status as a Foreign Private Issuer

New VIWO will convert to foreign private issuer status within the meaning of the rules under the Exchange Act upon the first available determination date, and, as such, New VIWO will be exempt from certain provisions applicable to United States domestic public companies. New VIWO may lose its status as a foreign private issuer in the future, causing it to incur substantial costs, time and resources.

Because New VIWO